New method for detecting and treating breast cancer subtypes

John­son & John­son is ear­mark­ing over $2 bil­lion to build a new bi­o­log­ics man­u­fac­tur­ing fa­cil­i­ty in Wil­son, NC, for a va­ri­ety of ther­a­pies for on­col­o­gy

Shi­no­bi Ther­a­peu­tics, an off-the-shelf cell ther­a­py de­vel­op­er, told End­points News it has hired its first chief sci­en­tif­ic and med­ical of­fi­cers as it al­so nabs two